Literature DB >> 28628975

Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/β-catenin signaling pathway in cervical cancer.

Fangfang Hua1, Shanshan Liu1, Lihong Zhu1, Ning Ma1, Shan Jiang2, Jun Yang3.   

Abstract

BACKGROUND: Cervical cancer is the most common gynecological malignancies in women worldwide. The previous study showed that lncRNA NNT-AS1 could play an important role in tumor development and metastasis of colorectal cancer. However, little is known about the function of NNT-AS1 in cervical cancer. The aim of this study was to investigate the expression profile of NNT-AS1 in cervical cancer and assess its possible molecular mechanism.
METHODS: Relative expression levels of NNT-AS1 in cervical cancer tissues were determined by qRT-PCR. The biologic functions of NNT-AS1 in cervical cancer were explored by MTT assay, transwell assay and flow cytometric analysis in vitro. The influence of NNT-AS1 on tumorigenesis was measured by mice xenograft model. In addition, we evaluated the activation of Wnt/β-catenin signaling pathway by luciferase assay and western blot.
RESULTS: Our results showed that NNT-AS1 expression in cervical cancer tissues compared with adjacent non-tumor tissues the overexpression of NNT-AS1 was positively associated with advanced FIGO stage, lymph node metastasis, depth of cervical invasion and poorer overall survival. Function assays showed that NNT-AS1 inhibition could suppress cervical cancer cells proliferation and invasion ability in vitro as well as the activation of Wnt/β-catenin signaling pathway. In vivo mice xenograft model revealed that silencing NNT-AS1 could reduce tumor growth in nude mice.
CONCLUSIONS: The results of the current study suggested that NNT-AS1 might play an important role in cervical carcinogenesis and might serve as a potentially therapeutic target and prognostic marker in the treatment of cervical cancer.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  -catenin; Cervical cancer; Long non-coding RNA; NNT-AS1; Wnt/β

Mesh:

Substances:

Year:  2017        PMID: 28628975     DOI: 10.1016/j.biopha.2017.03.057

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  30 in total

1.  High expression of long non-coding RNA NNT-AS1 facilitates progression of cholangiocarcinoma through promoting epithelial-mesenchymal transition.

Authors:  Yulei Gu; Chao Li; Lili Xiao; Juan Li; Hui Pei; Dong Xu; Yumin Jiang; Xiaofan Zhang; Luanluan Zhang; Kongfei Li; Zhiqiang Zhu; Xiaolong Chen
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

2.  Gefitinib suppresses cervical cancer progression by inhibiting cell cycle progression and epithelial-mesenchymal transition.

Authors:  Jianyun Zheng; Jianxin Yu; Min Yang; Li Tang
Journal:  Exp Ther Med       Date:  2019-07-09       Impact factor: 2.447

3.  Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.

Authors:  Changhui Li; Shouyun Zhang; Tongguo Qiu; Yuanji Wang; David M Ricketts; Chao Qi
Journal:  Cancer Biol Ther       Date:  2018-11-29       Impact factor: 4.742

4.  Knockdown of Rhotekin 2 expression suppresses proliferation and induces apoptosis in colon cancer cells.

Authors:  Xueqin Pang; Rui Li; Dongtao Shi; Xudong Pan; Chen Ma; Guangbo Zhang; Chuanyong Mu; Weichang Chen
Journal:  Oncol Lett       Date:  2017-10-13       Impact factor: 2.967

5.  Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis.

Authors:  Ye-Bin Lu; Qin Jiang; Man-Yi Yang; Ji-Xiang Zhou; Qi Zhang
Journal:  Oncotarget       Date:  2017-09-28

Review 6.  Wnt signaling in cervical cancer?

Authors:  Min Yang; Min Wang; Xianping Li; Yixin Xie; Xiaomeng Xia; Jingjing Tian; Kan Zhang; Aiguo Tang
Journal:  J Cancer       Date:  2018-03-20       Impact factor: 4.207

7.  High nuclear expression of APE1 correlates with unfavorable prognosis and promotes tumor growth in hepatocellular carcinoma.

Authors:  Xiaohua Lu; Hui Zhao; Hongxin Yuan; Yushan Chu; Xiaoqing Zhu
Journal:  J Mol Histol       Date:  2021-01-04       Impact factor: 2.611

8.  Long non‑coding RNA NNT‑AS1 knockdown represses the progression of gastric cancer via modulating the miR‑142‑5p/SOX4/Wnt/β‑catenin signaling pathway.

Authors:  Jianfeng Zhang; Kai Zhang; Yingkui Hou
Journal:  Mol Med Rep       Date:  2020-05-18       Impact factor: 2.952

9.  LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis.

Authors:  Yanjie Liu; Ruixia Guo; Yuhuan Qiao; Liping Han; Mingzhu Liu
Journal:  Cancer Cell Int       Date:  2020-05-24       Impact factor: 5.722

10.  Longitudinal Analysis of Gene Expression Changes During Cervical Carcinogenesis Reveals Potential Therapeutic Targets.

Authors:  Lijun Yu; Meiyan Wei; Fengyan Li
Journal:  Evol Bioinform Online       Date:  2020-05-18       Impact factor: 1.625

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.